Clinical TrialID 7758
Clinical Trial of Jinzhen Oral Liquid in Treating Children With COVID-19 Infection
NCT05507489
COVID-19|Child, Only
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Formula: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 7758
- Evidence Id
- 7758
- Core Evidence Id
- 7758
- Source Clinical Trial Id
- 7753
- Herb2 Clinical Trial Id
- HBCT007753
- Nct Id
- NCT05507489
- Title
- Clinical Trial of Jinzhen Oral Liquid in Treating Children With COVID-19 Infection
- Status
- Phase
- Study Result
- No
- Study Condition
- COVID-19|Child, Only
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DRUG: Jinzhen oral liquid or Jinhuaqinggan granules
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Child, Adult
- Enrollment
- 240
- Outcome Measure
- First negative time of COVID-19, First negative time of COVID-19, up to 6 months
- Sponsor Collaborator
- The Affiliated Hospital of Qingdao University
- Funded By
- OTHER
- Location
- Phase I Clinical Research Center, Qingdao, Shandong, 266003, China
- Other Id
- JZ-2022-nCoV-0.1
- Start Date
- 2022-03-18
- Primary Completion Date
- 2022-09-10
- Completion Date
- 2023-03-17
- First Posted
- 2022-08-19
- Results First Posted
- Last Update Posted
- 2022-08-19
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT05507489
- Title Cn
- Title En
- Clinical Trial of Jinzhen Oral Liquid in Treating Children With COVID-19 Infection
- Bilingual Status
- semi_complete